|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/404 | |||
| A61P 31/14 |
| (11) | Patento numeris | 2416765 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10714126.9 |
| Europos patento paraiškos padavimo data | 2010-04-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/029933 |
| Data | 2010-04-05 |
| (87) | Numeris | WO 2010/117939 |
| Data | 2010-10-14 |
| (30) | Numeris | Data | Šalis |
| 166922 P | 2009-04-06 | US |
| (72) |
LAHSER, Frederick, C., US
GU, Zhengxian, US
|
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court,, South Plainfield, NJ 07080,
US
|
| (54) | HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS |
| HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS |